- Flora Growth is building on its cannabis brand globalization efforts with two partnerships that expand its product portfolio and its research efforts in the United States and United Kingdom
- Flora’s partnership with former NFL athlete Ricky Williams has delivered its first product — a cannabis one-hitter accessory designed to provide a unique experience emblematic of Williams’ active lifestyle brand
- The company’s acquisition of the Masaya CBD brand developed by a cell biologist on Flora’s board of directors gives the company a formulation suitable for its current clinical trial efforts in the United Kingdom, and a well-received brand designed to help seizure patients
- Flora’s cultivation operations are centered at its Colombia facility, and recent regulatory changes there have made it easier for Flora to supply its brands in the United States and elsewhere
On the heels of a year in which global cannabis market brand-builder Flora Growth (NASDAQ: FLGC) saw rapid expansion of its cultivation, manufacturing and distribution operations that support the company’s business divisions for cosmetics, hemp textiles and food and beverage products, Flora is increasing its offerings by bringing a promising CBD brand into its fold and introducing a new product for quality cannabis experiences.
The acquisition of cell biologist Dr. Annabelle Manalo-Morgan’s Masaya brand gives Flora Growth its first offering under its Flora Life Sciences division as well as a patent-pending formulation for use in Flora’s current clinical trials with the University of Manchester in the United Kingdom (https://ibn.fm/CVd5N).
The launch of the global clinical trials was announced in October, heralding an effort to study the effects of Flora’s cannabis on fibromyalgia and chronic pain patients (https://ibn.fm/yduqw). Manalo-Morgan developed the formulation for Masaya after her son was born with a condition that led him to suffer from as many as 200 seizures per day.
Manalo-Morgan’s son initially underwent surgery that removed nearly 40 percent of his brain, but Manalo-Morgan’s discovery of CBD’s medicinal potential and development of Masaya’s formulation provided her a non-surgical path for ensuring her son’s well-being.
“He has no developmental deficits. If you saw him, you would never know there was a thing wrong with him. He is not autistic, delayed, nothing. He is a normal 5-year-old boy,” Manalo-Morgan told a news reporter as her son prepared to enter kindergarten last year (https://ibn.fm/MEvmD). “If I didn’t do this, my son would most likely be tied to a wheelchair, wouldn’t speak, would still be eating out of a tube. But luckily his mom is a scientist.”
Masaya has been used by thousands of consumers since its development with positive testimonials.
“Amplifying Dr. Annabelle and her son’s beautiful story and improving the well-being of people around the world is our aim,” Flora Chairman and CEO Luis Merchan stated in the company’s news release. “This acquisition allows us to deliver on our promise to invest in safe, thorough, cutting-edge scientific research that can bring meaningful change via an efficacious and accessible product offering for people worldwide.”
On May 18, Flora also announced the development of a custom accessory for cannabis use in collaboration with cannabis lifestyle brand Highsman, which was founded by former NFL running back Ricky Williams.
The patent-pending Highsman Helix one-hitter accessory is the first product introduced under the partnership between Highsman and Flora’s cannabis accessories brand Vessel (https://ibn.fm/haBI4). It is crafted in non-toxic brass and uniquely designed to offer “the perfect combination of filtering and cooling.”
Vessel’s other luxury accessories include a high-end line of vape pen batteries and dry-herb accessories, while Highsman also markets apparel and other accessories designed to appeal to people with active lifestyles, inspired by Williams’ success.
For more information, visit the company’s website at www.FloraGrowth.com.
NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.